- Home
- Articles
- latamerica
- autoimmunity
Refine by
Autoimmunity Articles & Analysis: This-Year
1 articles found
In June 2025, Capstan Therapeutics announced the initiation of a Phase I clinical trial for CPTX2309, an in vivo CAR-T candidate targeting B-cell–mediated autoimmune diseases. The therapy uses targeted lipid nanoparticles (tLNPs) to deliver CAR-encoding mRNA directly to immune cells. ...
